Skip to main content
. 2024 Jan 31;13(3):e033562. doi: 10.1161/JAHA.123.033562

Figure 2. Aspirin use and CHD events by lipoprotein(a) level in propensity‐matched cohort.

Figure 2

These cumulative incidence curves depict CHD risk for 4 categories based on lipoprotein(a) level and baseline aspirin use. Participants with lipoprotein(a) >50 mg/dL without aspirin use demonstrated the highest event rate, while participants with lipoprotein(a) >50 mg/dL with aspirin use demonstrated similar risk as those with lipoprotein(a) ≤50 mg/dL regardless of aspirin use. CHD indicates coronary heart disease; and Lp(a), lipoprotein(a).